Moderna
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called... Wikipedia
- Formerly called: ModeRNA Therapeutics, (2010–2018)
- Type: Public
- Traded as: NASDAQ: MRNA, Nasdaq-100 component, S&P 500 component
- ISIN: [ ISIN: [ US60770K1079]]
- Industry: Biotechnology
- Founders: Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
- Key people: Stéphane Bancel (CEO), Noubar Afeyan (chairman), Stephen Hoge (president), David Meline (CFO)
- Products: Spikevax, Vaccine candidates
- Revenue: US$6.848 billion (2023)
- Operating income: US$-4.24 billion (2023)
- Total assets: US$18.43 billion (2023)
- Total equity: US$13.85 billion (2023)
- Owners: Stéphane Bancel (7.3%), Noubar Afeyan (5.0%), Robert S. Langer (4.0%), Stephen Hoge (1.3%)
- Number of employees: 5,600(2023)
- Website: modernatx.com
- Data source: DuckDuckGo